Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Groenemeyer

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Chemistry|July 1, 1995
Apolipoprotein E genotyping on agarose gelsP W Reymer, B E Groenemeyer, R van de Burg, et al.
Nucleic Acids Research|November 25, 1991
HindIII-polymorphism in the LPL-gene detected by PCRT Bruin, P W Reymer, B E Groenemeyer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1997
Ser447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic malesJ A Kuivenhoven, B E Groenemeyer, J M Boer, et al.
Nature Genetics|May 1, 1995
A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosisP W Reymer, E Gagné, B E Groenemeyer, et al.
Human Molecular Genetics|September 1, 1995
A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemiaP W Reymer, B E Groenemeyer, E Gagné, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1995
Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL geneH Zhang, P W Reymer, M S Liu, et al.
Journal of Lipid Research|April 7, 1999
Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteinsH E Henderson, J J Kastelein, A H Zwinderman, et al.
Clinical Genetics|April 29, 1998
The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study GroupJ J Kastelein, B E Groenemeyer, D M Hallman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Chemistry|July 1, 1995
Apolipoprotein E genotyping on agarose gelsP W Reymer, B E Groenemeyer, R van de Burg, et al.
Nucleic Acids Research|November 25, 1991
HindIII-polymorphism in the LPL-gene detected by PCRT Bruin, P W Reymer, B E Groenemeyer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1997
Ser447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic malesJ A Kuivenhoven, B E Groenemeyer, J M Boer, et al.
Nature Genetics|May 1, 1995
A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosisP W Reymer, E Gagné, B E Groenemeyer, et al.
Human Molecular Genetics|September 1, 1995
A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemiaP W Reymer, B E Groenemeyer, E Gagné, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1995
Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL geneH Zhang, P W Reymer, M S Liu, et al.
Journal of Lipid Research|April 7, 1999
Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteinsH E Henderson, J J Kastelein, A H Zwinderman, et al.
Clinical Genetics|April 29, 1998
The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study GroupJ J Kastelein, B E Groenemeyer, D M Hallman, et al.
Pageof 1